DK0610356T3 - Behandling af bakteriel dysenteri - Google Patents

Behandling af bakteriel dysenteri

Info

Publication number
DK0610356T3
DK0610356T3 DK92922817T DK92922817T DK0610356T3 DK 0610356 T3 DK0610356 T3 DK 0610356T3 DK 92922817 T DK92922817 T DK 92922817T DK 92922817 T DK92922817 T DK 92922817T DK 0610356 T3 DK0610356 T3 DK 0610356T3
Authority
DK
Denmark
Prior art keywords
gal
beta
treatment
slt
agent
Prior art date
Application number
DK92922817T
Other languages
Danish (da)
English (en)
Inventor
Glen D Armstrong
Murray R Ratcliffe
Original Assignee
Synsorb Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synsorb Biotech Inc filed Critical Synsorb Biotech Inc
Application granted granted Critical
Publication of DK0610356T3 publication Critical patent/DK0610356T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK92922817T 1991-10-18 1992-10-19 Behandling af bakteriel dysenteri DK0610356T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77873291A 1991-10-18 1991-10-18
PCT/US1992/008929 WO1993008209A1 (fr) 1991-10-18 1992-10-19 Diagnostic et traitement de la dysenterie bacterienne

Publications (1)

Publication Number Publication Date
DK0610356T3 true DK0610356T3 (da) 2001-02-19

Family

ID=25114261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92922817T DK0610356T3 (da) 1991-10-18 1992-10-19 Behandling af bakteriel dysenteri

Country Status (9)

Country Link
US (3) US5620858A (fr)
EP (2) EP1018342A3 (fr)
AT (1) ATE198991T1 (fr)
CA (1) CA2121604C (fr)
DE (2) DE69231675T2 (fr)
DK (1) DK0610356T3 (fr)
ES (2) ES2150888T1 (fr)
GR (1) GR3035665T3 (fr)
WO (1) WO1993008209A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150888T1 (es) * 1991-10-18 2000-12-16 Synsorb Biotech Inc Diagnosis y tratamiento de la disenteria bacteriana.
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea
US5627163A (en) * 1995-06-05 1997-05-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5811409A (en) * 1995-06-05 1998-09-22 Synsorb Biotech, Inc. Treatment of cholera
US5661131A (en) * 1995-06-05 1997-08-26 Synsorb Biotech, Inc. Treatment of cholera
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5891860A (en) * 1996-03-11 1999-04-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US6069137A (en) * 1996-03-11 2000-05-30 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
AU733712B2 (en) * 1996-06-21 2001-05-24 Synsorb Biotech Inc. Use of oligosaccharides for neutralising E. coli toxins
JPH107575A (ja) * 1996-06-21 1998-01-13 Synsorb Biotec Inc 細菌性赤痢の処置
US6013634A (en) * 1996-11-08 2000-01-11 Synsorb Biotech, Inc. Solid support matrices containing a toxin binding oligosaccharide
US5846943A (en) * 1996-11-08 1998-12-08 Synsorb Biotech, Inc. Solid support matricles containing a toxin binding oligosaccharide
US5910579A (en) * 1997-01-10 1999-06-08 Synsorb Biotech Inc. Processes for the preparation of αGal(1->4)βGal (1->4) Glc-OR
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
ZA991410B (en) 1998-02-23 1999-10-06 Synsorb Biotech Inc Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
US7220596B2 (en) * 1998-04-15 2007-05-22 Utah State University Real time detection of antigens
NZ508172A (en) 1998-04-15 2003-08-29 Univ Utah State Real time detection of antigens
US6310043B1 (en) * 1998-08-07 2001-10-30 Governors Of The University Of Alberta Treatment of bacterial infections
US5962423A (en) * 1998-08-07 1999-10-05 The Governors Of The University Of Alberta Treatment of bacterial dysentery
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide
US20060051440A1 (en) * 2002-09-10 2006-03-09 Joel Moss Factors that bind intestinal toxins
BE1019290A5 (nl) 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070189D1 (en) * 1979-03-16 1985-03-28 Merieux Inst Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (fr) * 1980-05-09 1986-02-26 LEFFLER, Hakon Derives d'hydrate de carbone pour inhiber l'adherence bacterienne
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
US4946943A (en) * 1985-06-20 1990-08-07 Will Bloch Purification of ribotoxins and their conjugates
US4863852A (en) * 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US5168063A (en) * 1990-07-27 1992-12-01 Wisconsin Alumni Research Foundation Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11
ES2150888T1 (es) * 1991-10-18 2000-12-16 Synsorb Biotech Inc Diagnosis y tratamiento de la disenteria bacteriana.
NZ251621A (en) * 1992-03-26 1996-04-26 Microcarb Inc Polyclonal antibodies to shiga-like toxins
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea

Also Published As

Publication number Publication date
EP0610356A1 (fr) 1994-08-17
ES2150888T1 (es) 2000-12-16
DE1018342T1 (de) 2001-01-11
EP0610356A4 (fr) 1995-03-29
US5620858A (en) 1997-04-15
CA2121604A1 (fr) 1993-04-29
GR3035665T3 (en) 2001-06-29
CA2121604C (fr) 2002-01-15
US5955449A (en) 1999-09-21
ATE198991T1 (de) 2001-02-15
EP1018342A2 (fr) 2000-07-12
DE69231675T2 (de) 2001-06-28
ES2154265T3 (es) 2001-04-01
DE69231675D1 (de) 2001-03-08
US5679653A (en) 1997-10-21
EP0610356B1 (fr) 2001-01-31
WO1993008209A1 (fr) 1993-04-29
EP1018342A3 (fr) 2001-04-11

Similar Documents

Publication Publication Date Title
ATE198991T1 (de) Behandlung bakterieller dysenterie
CA2127111A1 (fr) Une methode pour preparer des medicaments oraux enrobes a delitage enterique renfermant des composes instables en milieu acide
MA28045A1 (fr) Solvat acetonique du dimethoxy docetaxel et son procede de preparation
DK0512661T3 (da) Makrocykliske polymer-kompleksdannere, deres komplekser, fremgangsmåde til deres fremstilling og farmaceutisk middel indeho
GR3020984T3 (en) Use of rifaximin and pharmaceutical compositions containing it in the treatment of gastric dyspepsia caused by helicobacter pylori.
NZ240838A (en) N,o-sulphated heparosans, preparation using e.coli and pharmaceutical compositions thereof
CZ49995A3 (en) Pharmaceutical preparation for oral administration
AU3042995A (en) Diagnostic testing for campylobacter jejuni or coli infection using antigens
GR3006730T3 (fr)
CA2139217A1 (fr) Vaccin destine a provoquer une reaction immunitaire contre des gangliosides n-glycolyles
AU641279B2 (en) Oligosaccharide derivatives
CA2223011A1 (fr) Derives d'oxazolidinone, leur preparation et leur application en therapeutique
MY113230A (en) Process for the preparation of 4,10-diacetoxy-2(alpha)- benzoyloxy-5(beta),20-epoxy-1,7(beta)-dihydroxy-9-oxo-tax-11-en- 13(alpha)-yl(2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpropionate trihydrate
NZ302632A (en) Treatment of traveller's diarrhea using a pharmaceutical composition containing a saccharide sequence
NZ504303A (en) Compounds and methods for the e coli mediated dysentery using antibiotics and shiga like toxin binding oligosaccharide compositions
NO914375L (no) 7-acyl-3-(substituerte carbamoyloxy)cefem-forbindelser ogfremgangsmaate for fremstilling av disse
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
BR0009052A (pt) Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica
CA2129676A1 (fr) Compositions antitussive de dextromethorphane
GR3008746T3 (fr)
HUT70766A (en) Pharmaceutical compositions containing immune stimulants for preventing bacterial infections
EP0376114A3 (fr) Dérivés de 9-dihydro-9-0-alkyldesmycosine
MY108106A (en) Complexes of polyadenylic acid with polyuridylic acid.
WO1997049431A3 (fr) UTILISATION D'OLIGOSACCHARIDES POUR NEUTRALISER DES TOXINES DE $i(E. COLI)
ZA954826B (en) New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same